BACKGROUND AND PURPOSE: Secondary-progressive MS is characterized by reduced acute inflammation and contrast enhancement but with increased axonal degeneration and cognitive/clinical disability that worsens with advanced disease. Relative recirculation, extracted from DSC is a surrogate measure of BBB integrity. We hypothesized that normal-appearing white matter relative recirculation is reduced in cognitively impaired compared with nonimpaired secondary-progressive MS, reflecting more advanced disease. MATERIALS AND METHODS: Cognitive performance was classified as impaired or nonimpaired by use of Minimal Assessment of Cognitive Function In MS test components. Demographic data, brain parenchymal fraction, WM lesion fraction, and weighted mean normal-appearing white matter relative recirculation were compared in cognitively dichotomized groups. Univariate and multivariate logistic regressions were used to study the association between cognitive test results and normal-appearing white matter relative recirculation. RESULTS: The mean (SD) age of 36 patients with secondary-progressive MS studied was 55.9 ± 9.3 years; 13 of 36 (36%) patients were male. A highly significant difference between normal-appearing white matter relative recirculation and WM lesion relative recirculation was present for all patients (P < .001). Normal-appearing white matter relative recirculation in impaired patients was significantly lower than in nonimpaired subjects for the Symbol Digit Modalities Test (P = .007), Controlled Word Association Test (P = .008), and Paced Auditory Serial Addition Test (P = .024). The Expanded Disability Status Scale demonstrated an inverse correlation with normal-appearing white matter relative recirculation (r = -0.319, P = .075). After adjustment for confounders, significant normal-appearing white matter relative recirculation reduction persisted for the Symbol Digit Modalities Test (P = .023) and the Paced Auditory Serial Addition Test (P = .047) but not for the Controlled Word Association Test (P = .13) in impaired patients. CONCLUSIONS: Significant normal-appearing white matter relative recirculation reduction exists in cognitively impaired patients with secondary-progressive MS, localizing to the domains of processing speed and working memory.
BACKGROUND AND PURPOSE: Secondary-progressive MS is characterized by reduced acute inflammation and contrast enhancement but with increased axonal degeneration and cognitive/clinical disability that worsens with advanced disease. Relative recirculation, extracted from DSC is a surrogate measure of BBB integrity. We hypothesized that normal-appearing white matter relative recirculation is reduced in cognitively impaired compared with nonimpaired secondary-progressive MS, reflecting more advanced disease. MATERIALS AND METHODS: Cognitive performance was classified as impaired or nonimpaired by use of Minimal Assessment of Cognitive Function In MS test components. Demographic data, brain parenchymal fraction, WM lesion fraction, and weighted mean normal-appearing white matter relative recirculation were compared in cognitively dichotomized groups. Univariate and multivariate logistic regressions were used to study the association between cognitive test results and normal-appearing white matter relative recirculation. RESULTS: The mean (SD) age of 36 patients with secondary-progressive MS studied was 55.9 ± 9.3 years; 13 of 36 (36%) patients were male. A highly significant difference between normal-appearing white matter relative recirculation and WM lesion relative recirculation was present for all patients (P < .001). Normal-appearing white matter relative recirculation in impairedpatients was significantly lower than in nonimpaired subjects for the Symbol Digit Modalities Test (P = .007), Controlled Word Association Test (P = .008), and Paced Auditory Serial Addition Test (P = .024). The Expanded Disability Status Scale demonstrated an inverse correlation with normal-appearing white matter relative recirculation (r = -0.319, P = .075). After adjustment for confounders, significant normal-appearing white matter relative recirculation reduction persisted for the Symbol Digit Modalities Test (P = .023) and the Paced Auditory Serial Addition Test (P = .047) but not for the Controlled Word Association Test (P = .13) in impairedpatients. CONCLUSIONS: Significant normal-appearing white matter relative recirculation reduction exists in cognitively impairedpatients with secondary-progressive MS, localizing to the domains of processing speed and working memory.
Authors: A Kassner; D J Annesley; X P Zhu; K L Li; I D Kamaly-Asl; Y Watson; A Jackson Journal: J Magn Reson Imaging Date: 2000-02 Impact factor: 4.813
Authors: Alan Jackson; Andrea Kassner; Deborah Annesley-Williams; Helen Reid; Xiau-Ping Zhu; Kah-Loh Li Journal: AJNR Am J Neuroradiol Date: 2002-01 Impact factor: 3.825
Authors: R B Parkinson; R O Hopkins; H B Cleavinger; L K Weaver; J Victoroff; J F Foley; E D Bigler Journal: Neurology Date: 2002-05-28 Impact factor: 9.910
Authors: Ralph H B Benedict; Diane Cookfair; Rebecca Gavett; Mark Gunther; Frederick Munschauer; Neeta Garg; Bianca Weinstock-Guttman Journal: J Int Neuropsychol Soc Date: 2006-07 Impact factor: 2.892
Authors: L A Dade; F Q Gao; N Kovacevic; P Roy; C Rockel; C M O'Toole; N J Lobaugh; A Feinstein; B Levine; S E Black Journal: Neuroimage Date: 2004-08 Impact factor: 6.556
Authors: Ralph H B Benedict; Bianca Weinstock-Guttman; Inna Fishman; Jitendra Sharma; Christopher W Tjoa; Rohit Bakshi Journal: Arch Neurol Date: 2004-02
Authors: M A van Buchem; R I Grossman; C Armstrong; M Polansky; Y Miki; F H Heyning; M P Boncoeur-Martel; L Wei; J K Udupa; M Grossman; D L Kolson; J C McGowan Journal: Neurology Date: 1998-06 Impact factor: 9.910
Authors: Eldar Eftekhari; Seyed-Parsa Hojjat; Rita Vitorino; Timothy J Carroll; Charles Grady Cantrell; Liesly Lee; Matthew W Taylor; Sarah A Morrow; Haddas Benhabib; Richard I Aviv; Andrea Kassner Journal: Neuroradiology Date: 2017-06-16 Impact factor: 2.804
Authors: Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Andrew Levy; Derek Leroith; Michal S Beeri Journal: Diabetologia Date: 2015-01-28 Impact factor: 10.122
Authors: A Beer; V Biberacher; P Schmidt; R Righart; D Buck; A Berthele; J Kirschke; C Zimmer; B Hemmer; M Mühlau Journal: J Neurol Date: 2016-05-13 Impact factor: 4.849
Authors: Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Hadas Hoffman; Rachel Preiss; Keren Koifmann; Lior Greenbaum; Andrew Levy; Jeremy M Silverman; Derek Leroith; Mary Sano; Michal Schnaider-Beeri Journal: Int J Geriatr Psychiatry Date: 2015-09-21 Impact factor: 3.485